HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
17 alpha- ethinyl- 3- isopropylsulfonyloxyestradiol
component of Deposiston
Also Known As:
turisteron; 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, 3-(2-propanesulfonate), (17alpha)-
Networked:
13
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Polycyclic Compounds: 6
Fused-Ring Compounds
Steroids: 70059
Norsteroids: 16
Norpregnanes: 2
Norpregnatrienes
Ethinyl Estradiol: 861
17 alpha-ethinyl-3-isopropylsulfonyloxyestradiol: 13
Hormones, Hormone Substitutes, and Hormone Antagonists
Hormones: 80400
Gonadal Hormones: 716
Gonadal Steroid Hormones: 7657
Estradiol Congeners: 358
Alkylated Estrogenic Steroids
Ethinyl Estradiol: 861
17 alpha-ethinyl-3-isopropylsulfonyloxyestradiol: 13
Related Diseases
1.
Prostatic Neoplasms (Prostate Cancer)
12/01/1987 - "
45 patients with prostatic cancer were treated conservatively with Turisteron at a dosage of 2 mg per week.
"
03/01/1987 - "
[Clinical experience using Turisteron in the treatment of prostatic cancer].
"
03/01/1987 - "
[Experiences in the treatment of advanced prostatic cancer using Turisteron with special reference to cardiovascular complications].
"
03/01/1987 - "
[Initial results of a phase IV multicenter clinical trial of Turisteron in the treatment of prostate cancer].
"
03/01/1987 - "
[Conservative therapy of prostate cancer using Turisteron].
"
2.
Carcinoma (Carcinomatosis)
03/01/1987 - "
It is reported on our experiences in the treatment of the advanced carcinoma of the prostate gland with Turisteron.
"
03/01/1987 - "
Due to the good tolerability and the only insignificant hepatotoxic reactions Turisteron is well suited for the long-term treatment of the carcinoma of the prostate gland.
"
11/01/1985 - "
[Turisteron in the treatment of advanced carcinoma of the prostate].
"
03/01/1987 - "
Turisteron is the basic therapeutic in the androgen-dependent carcinoma of the prostate gland.
"
03/01/1987 - "
In connection with the slight stress of the patients (application form, side effects) ethinylestradiol sulfonate (Turisteron) is an effective estrogen in the long-term treatment of the advanced carcinoma of the prostate gland.
"
3.
Neoplasms (Cancer)
12/01/1985 - "
Turisteron was able to normalize the 5 year survival rate in men with advanced non-metastatic cancer (T3NxM0) and to increase the survival rate significantly in men with metastatic cancer (T3-4, Nx, M1).
"
4.
Breast Neoplasms (Breast Cancer)
01/01/1982 - "
Forty late postmenopausal patients with metastatic breast cancer received Turisteron.
"
01/01/1982 - "
The risk-response relationship for Turisteron in older patients is favourable compared to that of polychemotherapy and it is therefore recommended that Turisteron be used as the initial therapy of choice for patients with metastatic breast cancer who are more than 5 years postmenopausal.
"
01/01/1982 - "
[Clinical experience with the depot estrogen Turisteron in the treatment of metastatic breast cancer (author's transl)].
"
Related Drugs and Biologics
1.
Estrogens (Estrogen)
2.
Testosterone (Sustanon)
3.
Hormones (Hormone)
4.
Cytarabine (Cytosar-U)
5.
Androgens
6.
Sulfates (Sulfates, Inorganic)
7.
Dexamethasone (Maxidex)
8.
Dehydroepiandrosterone (DHEA)
9.
Androstenedione (4 Androstene 3,17 dione)
10.
Transaminases (Aminotransferases)
Related Therapies and Procedures
1.
Therapeutics
2.
Orchiectomy (Orchidectomy)
3.
Combination Drug Therapy (Combination Chemotherapy)
4.
Conservative Treatment